Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5AP | P20292 | 10/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | CREBBP | Q92793 | 2/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.33 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.33 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.33 |
| ▸ | EP300 | Q09472 | 1/20 | 0.33 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.32 |
| ▸ | WHR1 | P49842 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL113587 | 0.88 | ALOX5AP (0.36) | ALOX5APMEN1KMT2A | |
| SCHEMBL7016133 | 0.88 | CFTR (0.40) | MEN1KMT2ACYP4F2CYP4A11KDM4C | |
| 2-Picolinic Acid SCHEMBL158317 | 0.82 | LPL (0.37) | ALOX5APMEN1KMT2ACREBBPCYP4F2 | |
| SCHEMBL113359 | 0.81 | ALOX5AP (0.34) | ALOX5APCREBBPEP300 | |
| SCHEMBL964490 | 0.78 | HTR2C (0.33) | ALOX5AP | |
| SCHEMBL962245 | 0.77 | HTR2C (0.33) | ALOX5AP | |
| SCHEMBL163419 | 0.72 | KCNH2 (0.37) | MEN1KMT2ACREBBPL3MBTL1KDM4C | |
| SCHEMBL112675 | 0.71 | KDM4C (0.46) | MEN1KMT2ACREBBPCYP4F2CYP4A11 | |
| SCHEMBL113428 | 0.71 | KCNH2 (0.36) | CREBBPL3MBTL1KDM4CEP300 | |
| SCHEMBL962706 | 0.70 | OPRM1 (0.35) | CREBBPL3MBTL1KDM4CEP300 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110015181-A1 | ALKYLAMINOPYRIDINE DERIVATIVE | BANYU PHARMACEUTICAL CO., LTD. (JP) | 2011-01-20 | — | — | US | disclosed |
| EP-2264026-A1 | ALKYLAMINOPYRIDINE DERIVATIVE | Banyu Pharmaceutical Co., Ltd. (JP) | 2010-12-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110015181-A1 | ALKYLAMINOPYRIDINE DERIVATIVE | NPY4R, NPY1R, NPY2R | ALOX5AP 1020/4885MEN1 1674/4885KMT2A 3144/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.